Recent studies have revealed that IFNγ could up-regulate and down-regulate the expression of CXCL10 and SLPI, respectively, which further resulted in increased AHR and steroid resistance in severe asthma (Raundhal et al., 2015; Oriss et al., 2017). The gene discussed is CXCL10; the disease is asthma.